Clinical trials demonstrate significant weight reductiontypically 1015% of initial body weight over 68 weeks (STEP clinical trial programme)though many patients experience periods where weight loss slows or stops entirely, commonly termed a plateau
The post hoc design, modest sample size, HIV-specific cohort, and 32-week follow-up limit generalizability
There's no research to support this, and doctors clearly inform patients that if they want to lose weight, they should use a targeted and medically approved program
If you choose to use cold medicines that contain decongestants, this effect can be magnified
Managing Digestive Health on GLP-1 Receptor Agonists Optimising digestive health whilst taking Mounjaro involves a combination of lifestyle modifications, dietary strategies, and clinical monitoring
21, 2025, the FDA announced that the semaglutide shortage was over, giving compounding pharmacies a deadline to stop distributing compounded semaglutide thats essentially identical to FDA-approved versions